Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 5 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. US 11578126

    Chimeric antigen receptor (CAR) comprising a CD19-binding domain

    AUTOLUS LIMITED · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  2. US 11564945

    Chimeric antigen receptor and use thereof

    Nanjing Legend Biotech Co., Ltd · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  3. US 11554140

    Nucleic acid, chimeric antigen receptor expression plasmid, chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer

    China Medical University Hospital · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted

  4. US 11535677

    Chimeric antigen receptors targeting BCMA and methods of use thereof

    LEGEND BIOTECH USA INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  5. US 11504385

    Proteolysis targeting chimeric molecule, preparation method, and application

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

  6. US 11479611

    HLA-G specific chimeric antigen receptor, nucleic acid, HLA-G specific chimeric antigen receptor expression plasmid, HLA-G specific chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer

    China Medical University Hospital · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  7. US 11479614

    Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptors

    AUTOLUS LIMITED · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  8. US 11479613

    Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins

    AUTOLUS LIMITED · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  9. US 11478510

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  10. US 11401332

    Proteolytically cleavable chimeric polypeptides and methods of use thereof

    The Regents of the University of California · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  11. US 11401322

    Immunoglobulin chimeric monomer-dimer hybrids

    BIOVERATIV THERAPEUTICS INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  12. US 11401317

    Human-CD123-targeting chimeric receptor ligand and application thereof

    Nanjing Legend Biotech Co., Ltd · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  13. US 11384154

    Targeted chimeric proteins and uses thereof

    Orionis Biosciences, Inc · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted

  14. US 11377660

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  15. US 11370827

    Chimeric factor VIII polypeptides and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  16. US 11359204

    Chimeric antigen receptors targeting B-cell maturation antigen

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  17. US 11345734

    Chimeric T cell

    AUTOLUS LIMITED · Granted May 31, 2022 · Expires May 26, 2042

    granted

  18. US 11344615

    Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in vero cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 31, 2022 · Expires May 26, 2042

    granted

  19. US 11325957

    Methods and compositions for reducing the immunogenicity of chimeric notch receptors

    Cell Design Labs, Inc. · Granted May 10, 2022 · Expires May 5, 2042

    granted

  20. US 11312939

    Constructs for chimeric antigen receptors

    Carisma Therapeutics Inc. · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted

  21. US 11299546

    FLT3-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  22. US 11299520

    Compositions comprising a chimeric bacterial surface layer protein and methods of use thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  23. US 11273214

    Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  24. US 11266720

    Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.